The Commission held a public hearing on rule refinements for accessible labeling and authorized the filing of related regulatory documents. Key discussions included a presentation by the Secretary of Health regarding strategic frameworks, approval of various ancillary utilization plans, and pharmacy technician training programs. The Commission also reviewed delegation agreements, discussed pharmacy service issues, and directed staff to update personnel application procedures regarding criminal conviction reporting. Additionally, the Commission addressed rulemaking for pharmacy personnel examinations and non-narcotic stimulant drugs, and reviewed updates on legislative proposals and upcoming conference attendance.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The commission conducted a business meeting covering various administrative and regulatory matters. Key topics included the approval of ancillary utilization plans and pharmacy technician training programs, as well as specific regular agenda items regarding facility approvals. Presentations were delivered on Health Systems Quality Assurance Division updates and the quarterly budget report. The commission addressed new business related to pharmacy service issues and workplace conditions, along with medication procurement issues for Acupuncture and Eastern Medicine Practitioners. Old business involved updates to policies and procedures and the UMPJE implementation guidance. Public hearings were held regarding rulemaking for mobile opioid treatment programs and clarifying ancillary utilization plans. Furthermore, the commission authorized several rule and legislative initiatives concerning animal euthanasia, pharmacy technician licensing, collaborative drug therapy agreements, and the scheduling of synthetic benzodiazepines. Finally, commission member leadership elections were conducted.
The commission addressed several business matters, including the approval of the consent agenda regarding ancillary utilization plans and technician training programs. Key discussions focused on the 2026 legislative session, the presentation by the National Associations of Boards of Pharmacy, and the official adoption of the UMPJE with a transition period. Members deliberated on various resolutions for the NABP annual meeting, reviewed study plans, and approved policy updates. Additionally, legislative and rule-making updates were discussed, specifically regarding changes of ownership requirements, pharmacy assistant regulations, and the strategic plan implementation. Staff reports provided insights into budget challenges, software transitions, and staff updates.
The Commission addressed several administrative and regulatory matters, including the approval of ancillary utilization plans and pharmacy technician training programs. A public hearing was held regarding rulemaking for medication assistance. Presentations were provided on the quarterly budget and the Healthcare Enforcement and Licensing Management System. The Commission reviewed panel study plans, updated nonresident pharmacy directives, and discussed various policy statements, guidance documents, and rule updates concerning topics such as euthanasia training guidelines, self-inspection worksheets, and tamper-resistant prescription requirements. Additionally, legislative updates and strategic plan implementation progress were noted, and legislative request concepts were discussed for future consideration.
Extracted from official board minutes, strategic plans, and video transcripts.
